ELI LILLY AND COMPANY;LILLY CHINA RESEARCH AND DEVELOPMENT CO., LTD.
发明人:
HUANG, Ping,RIBE, Seth Dietrich
申请号:
CNCN2014/085925
公开号:
WO2016/033776A1
申请日:
2014.09.04
申请国别(地区):
CN
年份:
2016
代理人:
摘要:
Provided are crystalline (2S)-3-[(3S,4S)-3-[(1R)-1-hydroxyethyl]-4-(4-methoxy-3-{[1-(5-methylpyridin-2-yl)azetidin-3-yl]oxy}phenyl)-3-methylpyrrolidin-1-yl]-3-oxopropane-1,2-diol, pharmaceutical compositions thereof and the use of the compound to treatment of overactive bladder.Cette invention concerne un (2S)-3-[(3S,4S)-3-[(1R)-1-hydroxyéthyl]-4-(4-méthoxy-3-{[1-(5-méthylpyridin-2-yl)azétidin-3-yl]oxy}phényl)-3-méthylpyrrolidin-1-yl]-3-oxopropane-1,2-diol cristallin, des compositions pharmaceutiques le contenant et l'utilisation du composé pour traiter la vessie hyperactive.